Drug Database
Back to search

Netherlands· NL-7afb3d407487

Lormetazepam Prolepha 2 mg, tabletten

A lormetazepam product containing lormetazepam, registered in Netherlands by Prolepha Research B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC N05CD06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLormetazepam Prolepha 2 mg, tablett…ATCN05CD06REGISTER NO.NL-7afb3d407487PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lormetazepamAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lormetazepam is registered in 9 of 19 countries.

Countries holding a registration under ATC N05CD06 (lormetazepam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search lormetazepam products by name

Lormetazepam · ATC N05CD06

9 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lormetazepam costs, country by country.

Normalised to the WHO defined daily dose (1 mg), the median price runs from $0.066 in Spain to $0.58 in Switzerland — a ×8.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lormetazepam · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.58
  • FR France$0.068
  • ES Spain$0.066
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LORMETAZEPAM
Manufacturer
Prolepha Research B.V.
Country
Netherlands (NL)
ATC code
N05CD06
ATC class
Lormetazepam
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    23459

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

44 interactions on record for lormetazepam.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lormetazepam against other medicinesHow interaction checks work

Lormetazepam · interactions on record

44 records

44 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lormetazepam in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lormetazepam products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Sedalor
  • Belgium · Loramet, Lormetazepam Eg
  • Cyprus · Aldosomnil, Sedalor
  • Germany · Ergocalm, Sedalam
  • Spain · Aldosomnil, Loramet
  • France · Lormetazepam Arrow
  • United Kingdom (Northern Ireland) · Lormetazepam, Lormetazepam Genus Pharmaceuticals
  • Italy · Axilium, Ipnolor
  • Luxembourg · Loramet, Lormetazepam Eg
  • Malta · Sedalor
  • Poland · Noctofer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2fd622c3-a322-49ab-aaf8-a637f8f463f3
GET /v1/drugs/2fd622c3-a322-49ab-aaf8-a637f8f463f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h23459_smpc.pdf",
  "strength": null,
  "atc_label": "Lormetazepam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg23459",
  "excipients": [
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POVIDON K 30 (E 1201)"
  ],
  "substances": [
    "LORMETAZEPAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h23459.pdf",
  "authorised_at": "1999/07/19",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "23459",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about lormetazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console